Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Melissa Eliot
Institution:
Thermo Fisher Scientific (United States)
Observed institution:
Thermo Fisher Scientific (United States)
ORCID:
0000-0003-3280-935X
Observed ORCID:
0000-0003-3280-935X
OpenAlex ID:
A5140136893
Who Achieves Minimal and Very Low Disease Activity in Psoriatic Arthritis? An Analysis of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
2026
·
Alexis Ogdie
, Chao Song
, et al.
·
The Journal of Rheumatology
·
1
PDF
71091 Real-world tildrakizumab effectiveness in the US by biologic experience and geographic region in the PPD CorEvitas Psoriasis Registry
2026
·
Benjamin Lockshin
, Alicia Beeghly
, et al.
·
Journal of the American Academy of Dermatology
73014 Real-world tildrakizumab persistence in the US by biologic experience and insurance coverage in the PPD CorEvitas Psoriasis Registry
2026
·
Benjamin Lockshin
, Alicia Beeghly
, et al.
·
Journal of the American Academy of Dermatology
73017 Regional differences in patient characteristics among US biologic initiators from the PPD CorEvitas Psoriasis Registry
2026
·
Vimal H. Prajapati
, Taylor Blachley
, et al.
·
Journal of the American Academy of Dermatology
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type